As of 2025-07-09, the EV/EBITDA ratio of Proteome Sciences PLC (PRM.L) is -14.78. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRM.L's latest enterprise value is 22.40 mil GBP. PRM.L's TTM EBITDA according to its financial statements is -1.51 mil GBP. Dividing these 2 quantities gives us the above PRM.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 21.6x | 16.3x |
| Forward P/E multiples | 10.7x - 15.6x | 12.4x |
| Fair Price | (10.09) - (12.48) | (11.86) |
| Upside | -431.9% - -510.6% | -490.2% |
| Date | EV/EBITDA |
| 2025-07-03 | -14.78 |
| 2025-07-02 | -14.78 |
| 2025-07-01 | -14.78 |
| 2025-06-30 | -14.80 |
| 2025-06-27 | -14.80 |
| 2025-06-26 | -14.80 |
| 2025-06-25 | -14.80 |
| 2025-06-24 | -14.80 |
| 2025-06-23 | -14.78 |
| 2025-06-20 | -14.78 |
| 2025-06-19 | -14.69 |
| 2025-06-18 | -14.88 |
| 2025-06-17 | -14.88 |
| 2025-06-16 | -15.41 |
| 2025-06-13 | -15.41 |
| 2025-06-12 | -15.41 |
| 2025-06-11 | -15.41 |
| 2025-06-10 | -14.92 |
| 2025-06-09 | -15.37 |
| 2025-06-05 | -15.21 |
| 2025-06-04 | -15.08 |
| 2025-06-03 | -15.37 |
| 2025-06-02 | -15.37 |
| 2025-05-30 | -15.37 |
| 2025-05-29 | -15.37 |
| 2025-05-28 | -15.37 |
| 2025-05-27 | -14.98 |
| 2025-05-23 | -15.51 |
| 2025-05-22 | -15.78 |
| 2025-05-21 | -16.66 |
| 2025-05-20 | -16.76 |
| 2025-05-19 | -16.66 |
| 2025-05-16 | -16.07 |
| 2025-05-15 | -15.21 |
| 2025-05-14 | -15.21 |
| 2025-05-13 | -15.41 |
| 2025-05-12 | -14.88 |
| 2025-05-09 | -14.39 |
| 2025-05-08 | -14.88 |
| 2025-05-07 | -14.71 |
| 2025-05-06 | -14.80 |
| 2025-05-02 | -14.20 |
| 2025-05-01 | -14.20 |
| 2025-04-30 | -14.20 |
| 2025-04-29 | -14.20 |
| 2025-04-28 | -14.20 |
| 2025-04-25 | -14.39 |
| 2025-04-24 | -15.00 |
| 2025-04-23 | -14.76 |
| 2025-04-22 | -14.39 |